Clinical Trials Browser

Phase 1 × Neoplasms × apatinib × Clear all

NCT03396211 2023-04-07

A Study to Evaluate Apatinib (Also Known as Rivoceranib) Plus Nivolumab in Participants With Unresectable or Metastatic Cancer

Phase 1 Completed

Neoplasm Metastasis, Neoplasms

NCT02836821 2017-02-27

Effect of Rifampicin on the Pharmacokinetics of Apatinib

Phase 1 Completed

Neoplasms

NCT00633490 2008-07-22

Study of Apatinib as an Inhibitor of Tumor Angiogenesis

Phase 1 Unknown

Neoplasms